Translate bio, inc. (TBIO)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17
Assets
Current assets:
Cash and cash equivalents

97,468

84,580

98,930

74,904

62,431

55,199

38,864

16,495

48,058

Short-term investments

57,627

104,098

111,233

71,961

60,154

88,904

122,236

1,000

9,997

Collaboration receivables

6,228

4,596

-

-

-

833

-

-

-

Prepaid expenses and other current assets

6,921

9,391

6,648

6,069

5,247

3,641

4,194

4,826

3,014

Restricted cash

950

950

950

950

1,025

1,025

1,025

1,966

1,966

Total current assets

169,194

203,615

217,761

153,884

128,857

149,602

166,319

24,287

63,035

Property and equipment, net

13,781

12,539

10,680

10,903

10,771

10,245

10,068

9,868

6,778

Right-of-use assets, net

10,268

10,400

10,527

10,650

10,769

-

-

-

-

Goodwill

21,359

21,359

21,359

21,359

21,359

21,359

21,359

21,359

21,359

Intangible assets, net

84,844

85,536

86,695

105,630

105,980

106,445

106,842

106,842

106,842

Deferred offering costs

-

-

-

123

-

-

-

3,976

511

Other assets

5,796

2,752

2,492

-

-

-

-

-

22

Total assets

305,242

336,201

349,514

302,549

277,736

287,651

304,588

166,332

198,547

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

6,297

15,968

3,407

3,347

4,192

5,168

3,111

6,219

4,594

Accrued expenses

7,478

7,072

8,767

7,246

6,452

6,547

5,806

5,758

5,888

Current portion of contingent consideration

-

-

-

-

-

-

-

2,387

1,296

Current portion of deferred revenue

26,760

18,100

12,603

9,015

5,708

2,572

1,042

-

-

Current portion of operating lease liability

573

530

489

449

411

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

307

Total current liabilities

41,108

41,670

25,266

20,057

16,763

14,287

9,959

14,364

12,085

Contingent consideration

94,203

103,655

100,399

120,233

115,344

103,642

118,211

91,382

79,713

Deferred revenue, net of current portion

15,328

25,256

30,046

34,192

38,017

41,841

44,024

-

-

Deferred tax liabilities

-

-

-

-

-

481

913

3,437

6,039

Deferred rent

-

-

-

-

-

2,105

2,064

2,023

1,329

Operating lease liability, net of current portion

11,931

12,084

12,230

12,370

12,504

-

-

-

-

Total liabilities

162,570

182,665

167,941

186,852

182,628

162,356

175,171

111,206

99,166

Commitments and contingencies (Notes 3, 4 and 14)

-

-

-

-

-

-

0

0

-

Redeemable convertible preferred stock (Series A, B and C), $0.001 par value; no shares and 145,833,064 shares authorized as of December 31, 2018 and 2017, respectively; no shares and 142,288,292 shares issued and outstanding as of December 31, 2018 and 2017, respectively

-

-

-

-

-

-

-

193,540

192,896

Stockholders' equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized as of March 31, 2020 and December 31, 2019, respectively; no shares issued and outstanding as of March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

-

-

Common stock, $0.001 par value; 200,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 60,037,663 shares and 60,022,067 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

60

60

60

51

45

45

45

10

10

Additional paid-in capital

515,535

512,231

509,294

422,309

374,113

371,257

369,614

59,096

55,204

Accumulated deficit

-373,778

-359,496

-328,460

-307,233

-279,401

-246,203

-240,166

-197,520

-148,808

Accumulated other comprehensive income

855

741

679

570

351

196

-76

-

79

Total stockholders' equity

142,672

153,536

181,573

115,697

95,108

125,295

129,417

-138,414

-93,515

Total liabilities and stockholders' equity

305,242

336,201

349,514

302,549

277,736

287,651

304,588

166,332

198,547